Every 10-Q that Aterian, Inc. (ATER) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ATER and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATER filings page.
Aterian, Inc. reported very limited continuing operations for the quarter ended June 30, 2026 while preparing for a transformational asset and equity transaction that closed in July. Continuing net revenue was only $7 thousand for the quarter and $25 thousand for the first half of 2026, compared with $88 thousand and $151 thousand in the prior-year periods. Loss from continuing operations was $3.96 million for the quarter and $7.40 million year-to-date, similar to 2025. After income from discontinued operations tied to brands being sold, the company posted a quarterly net loss of $0.49 million and a six‑month net loss of $6.62 million.
As of June 30, 2026, Aterian held $2.55 million in cash and $23.53 million in total assets, including $18.18 million classified as held for sale related to marquee brands being sold to Trademark Global for $18.0 million in cash. The company also completed a preferred stock financing with $7.0 million in aggregate proceeds from investor David E. Lazar, who subsequently became CEO and beneficial owner of about 95.8% of voting securities. Management disclosed that, despite debt repayment and cost reductions, the small scale of the remaining legacy brands and ongoing macro pressures continue to raise substantial doubt about Aterian’s ability to continue as a going concern over the next year.
Aterian, Inc. reported continued weak operating results and outlined a transformative restructuring in its quarter ended March 31, 2026. From continuing operations, net revenue fell to $18 thousand and the company posted a net loss of $6.1 million, including $3.4 million of non‑cash impairment tied to brands classified as discontinued operations.
Total assets declined to $22.2 million and stockholders’ equity fell to $9.5 million, while cash and restricted cash decreased to $3.5 million. Management disclosed substantial doubt about Aterian’s ability to continue as a going concern and is relying on a pair of April 27, 2026 agreements to stabilize its position.
Under an Asset Purchase Agreement, Aterian agreed to sell marquee brands such as Mueller Living, PurSteam, and hOmeLabs to Trademark Global for $18 million in cash, and it entered a Securities Purchase Agreement with David E. Lazar for $7.0 million of Series AA and Series AAA preferred stock. After closing, Lazar is expected to hold about 95.13% of fully diluted shares, subject to stockholder approval and performance conditions. The filing also highlights Nasdaq minimum‑bid price noncompliance, workforce reductions, a voluntary product recall with a $100,000 class‑action settlement, and a planned recognition of $1.2 million in Section 301 duty recoveries in the second quarter.
Aterian, Inc. reported Q3 2025 results with net revenue of $19,021 (thousands) and gross profit of $10,671 (thousands). Operating loss was $2,043 (thousands) and net loss was $2,281 (thousands), or $0.28 per share. Cash was $7,588 (thousands) at September 30, 2025, and year‑to‑date operating cash flow was $(9,853) (thousands).
The company disclosed substantial doubt about its ability to continue as a going concern, citing ongoing losses, tariff-driven cost pressures, and dependence on external capital. Aterian amended its MidCap credit facility on August 29, 2025, temporarily reducing the minimum liquidity covenant to $5.0M, increasing to $6.8M after delivering a qualifying liquidity certificate; it remained in compliance as of quarter‑end.
A fixed cost reduction plan announced on May 14, 2025 resulted in $1.8M restructuring charges year‑to‑date and is expected to generate $5–$6M in annualized savings. The company also accrued about $0.4M for product remediation costs. Shares outstanding were 10,207,835 as of September 30, 2025.
Aterian, Inc. reported a significant decline in sales and continued losses in the first half of 2025 as trade policy changes and softer consumer demand weighed on its business. Net revenue for the quarter ended June 30, 2025 was $19.46 million, down 30.5% from $27.98 million a year earlier, and six-month revenue fell to $34.82 million from $48.20 million. The company recorded a quarterly net loss of $4.86 million and a six-month net loss of $8.76 million, with net loss per share of $0.63 for the quarter and $1.16 year-to-date. Gross margin contracted to 54.3% for the quarter as tariffs raised cost of goods sold and the company implemented price increases that reduced unit volumes.
The balance sheet shows $10.50 million of unrestricted cash and total cash and restricted cash of $11.69 million at June 30, 2025, inventory of $18.50 million, and an accumulated deficit of $720.4 million. Aterian is in compliance with its MidCap credit covenants as of June 30, 2025 and expects compliance through at least September 30, 2026, but discloses substantial doubt about near-term liquidity without additional capital. The company recognized restructuring charges of approximately $1.8 million tied to a May 2025 cost reduction plan expected to yield annualized savings of $5–6 million.